A urine test strip that could transform kidney diet care?

NCT ID NCT07746037

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial is testing whether a connected urine test strip device, called URIKI, can help people with stage 4 or 5 chronic kidney disease monitor their diet from home. Participants will use the device daily for 10 days, logging meals and other health information in a mobile app. The goal is to see if this approach can make dietitian consultations more efficient and improve nutritional care for people with advanced kidney disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
URIKI Digital Urinary Monitoring System (connected urine test strips, portable reader, mobile app, and healthcare platform)
What this could lead to
If effective, this device could make it easier for people with advanced kidney disease to track their diet at home and help dietitians provide more efficient, personalized nutritional care.
What could go wrong
This is an early-stage study focused on feasibility and workflow, not on health outcomes. The device may not prove accurate or practical for daily use, and results may not apply beyond the study setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (CKD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Pitié-Salpêtrière - APHP, Département de Néphrologie, Néphrologie Ambulatoire et Onco-Néphrologie

    Paris, France

  • Hôpital Tenon - APHP, Département de Néphrologie, Néphrologie Ambulatoire et Onco-Néphrologie

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.